Efficacy & Clinical Studies On TMS Therapy

Learn more from the professionals in the medical industry about TMS Therapy

Efficacy Study


The STAR*D Study is the largest trial ever done on psychotropic medications. Over seven years, the remission rates of more than 4,000 patients on medications were studied.

The results found that:

  • First-line treatment (1st medication) produced a 27.5% chance of remission
  • Second-line treatment (2nd medication) produced a 21.2% chance of remission
  • Third-line treatment (3rd medication) produced a 16.2% chance of remission.
  • If participants failed on three medications, the fourth medicine produced a 6.9% chance of remission.

If a doctor handed you a prescription and told you that because you're on your fourth medication, it has only a 7% chance of working, wouldn't you ask if there was another option?

There is - TMS Therapy.

Clinical Studies


The New England Comparative Effectiveness Public Advisory Council Public Meeting – December 9, 2011

Nonpharmacologic Interventions for Treatment-Resistant Depression: Supplementary Data and Analyses to the Comparative Effectiveness Review of the Agency for Healthcare Research and Quality

FINAL MEETING REPORT – Completed by The Institute for Clinical and Economic Review, December 22, 2011

Click To Read The Full Report >>


A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

David L. Dunner, MD; Scott T. Aaronson, MD; Harold A. Sackeim, PhD; Philip G. Janicak, MD; Linda L. Carpenter, MD; Terrence Boyadjis, MD;
David G. Brock, MD; Dafna Bonneh-Barkay, PhD; Ian A. Cook, MD;
Karl Lanocha, MD; H. Brent Solvason, MD, PhD; and Mark A. Demitrack, MD

Click To Read The Full Report >>